EP1274716A4 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides

Info

Publication number
EP1274716A4
EP1274716A4 EP01926385A EP01926385A EP1274716A4 EP 1274716 A4 EP1274716 A4 EP 1274716A4 EP 01926385 A EP01926385 A EP 01926385A EP 01926385 A EP01926385 A EP 01926385A EP 1274716 A4 EP1274716 A4 EP 1274716A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01926385A
Other languages
German (de)
French (fr)
Other versions
EP1274716A1 (en
Inventor
Y Tom Tang
Vinod Asundi
Ping Zhou
Aidong J Xue
Feiyan Ren
Jie Zhang
Jian-Rui Wang
Yonghong Yang
Qing A Zhao
Ryle W Goodrich
Chenghua Liu
Radoje T Drmanac
Yunqing Ma
Zhiwei Wang
Tom Wehrman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/728,628 external-priority patent/US20020009786A1/en
Priority claimed from US09/783,066 external-priority patent/US20020142302A1/en
Priority claimed from US09/816,828 external-priority patent/US20020150898A1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Priority to EP05005147A priority Critical patent/EP1591448A3/en
Publication of EP1274716A1 publication Critical patent/EP1274716A1/en
Publication of EP1274716A4 publication Critical patent/EP1274716A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01926385A 2000-04-18 2001-04-16 Novel nucleic acids and polypeptides Withdrawn EP1274716A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05005147A EP1591448A3 (en) 2000-04-18 2001-04-16 Novel nucleic acids and polypeptides

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US783066 1991-10-25
US55292900A 2000-04-18 2000-04-18
US522929 2000-04-18
US66831700A 2000-09-22 2000-09-22
US668317 2000-09-22
US69578300A 2000-10-24 2000-10-24
US695783 2000-10-24
US09/728,628 US20020009786A1 (en) 2000-04-18 2000-12-01 Novel nucleic acids and polypeptides
US728628 2000-12-01
US77016001A 2001-01-26 2001-01-26
US770160 2001-01-26
US09/783,066 US20020142302A1 (en) 2000-04-18 2001-02-13 Novel nucleic acids and polypeptides
US09/816,828 US20020150898A1 (en) 2000-04-18 2001-03-22 Novel nucleic acids and polypeptides
US816828 2001-03-22
PCT/US2001/008655 WO2001079254A1 (en) 2000-04-18 2001-04-16 Novel nucleic acids and polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP05005147A Division EP1591448A3 (en) 2000-04-18 2001-04-16 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1274716A1 EP1274716A1 (en) 2003-01-15
EP1274716A4 true EP1274716A4 (en) 2004-08-11

Family

ID=27569838

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01926385A Withdrawn EP1274716A4 (en) 2000-04-18 2001-04-16 Novel nucleic acids and polypeptides

Country Status (4)

Country Link
EP (1) EP1274716A4 (en)
AU (1) AU2001252926A1 (en)
CA (1) CA2406121A1 (en)
WO (1) WO2001079254A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269922A1 (en) * 2002-07-26 2004-02-16 Incyte Corporation Nucleic acid-associated proteins
BR112013026199A2 (en) * 2011-04-15 2017-11-07 Compugen Ltd isolated polypeptide, fusion protein, nucleic acid sequence, expression vector or a virus, recombinant cell, method of producing a soluble ectodomain polypeptide or fusion protein or fragment thereof, pharmaceutical composition, use of a monoclonal antibody or polyclonal or antigen-binding fragment thereof, use of antibody or antigen-binding fragment, use of any of an isolated polypeptide, method of regulating cytokines, induction of t-cell expansion, promotion of cell immunity antigen specific t and promotion of cd4 + and / or cd8 + t cell activation in a subject, method for enhancing an immune response secondary to an antigen in a patient, method of using at least one of: an isolated polypeptide, method for treatment or prevention of an immune system related condition, method for treating or preventing an infectious disease a, method for diagnosing a disease in a subject, method of producing a soluble ectodomain polypeptide tmem25, vsig10, ly6g6f, or fusion protein or fragment thereof, monoclonal or polyclonal antibody or antigen-binding fragment thereof, immunotherapy in a patient and method for combining therapeutic vaccination with an antigen in conjunction with administration of either of a polypeptide
CN112812168A (en) * 2021-01-19 2021-05-18 浙江辉肽生命健康科技有限公司 Bioactive peptide GLNMCRQCF, and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YOSHIHARA YOSHIHIRO ET AL: "OCAM: A new member of the neural cell adhesion molecule family related to zone-to-zone projection of olfactory and vomeronasal axons", JOURNAL OF NEUROSCIENCE, vol. 17, no. 15, 1997, pages 5830 - 5842, XP002273373, ISSN: 0270-6474 *

Also Published As

Publication number Publication date
AU2001252926A1 (en) 2001-10-30
CA2406121A1 (en) 2001-10-25
WO2001079254A1 (en) 2001-10-25
EP1274716A1 (en) 2003-01-15

Similar Documents

Publication Publication Date Title
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (en) Novel nucleic acids and polypeptides
EP1341804A4 (en) Novel nucleic acids and polypeptides
EP1504099A4 (en) Novel nucleic acids and polypeptides
EP1381621A4 (en) Novel nucleic acids and polypeptides
EP1432800A4 (en) Novel nucleic acids and polypeptides
EP1470238A4 (en) Novel nucleic acids and polypeptides
EP1242443A4 (en) Novel nucleic acids and polypeptides
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
IL206414A0 (en) Novel receptor nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1430112A4 (en) Novel nucleic acids and polypeptides
EP1276751A4 (en) Novel nucleic acids and polypeptides
EP1368475A4 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
WO2002016439A8 (en) Novel nucleic acids and polypeptides
EP1341803A4 (en) Novel nucleic acids and polypeptides
AU2001263005A8 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021031

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7C 07H 21/04 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040622

17Q First examination report despatched

Effective date: 20041112

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050517